{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T12:18:34Z","timestamp":1699618714893},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T00:00:00Z","timestamp":1346371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-244x-12-130","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T02:25:12Z","timestamp":1346379912000},"source":"Crossref","is-referenced-by-count":2,"title":["Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Joseph","family":"Peuskens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Porsdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Pecenak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Handest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"D'yachkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radim","family":"Brousil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Deberdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,31]]},"reference":[{"issue":"12 Suppl 14","key":"1103_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852900025852","volume":"11","author":"JM Kane","year":"2006","unstructured":"Kane JM: Utilization of long-acting antipsychotic medication in patient care. CNS Spectr. 2006, 11 (12 Suppl 14): 1-7.","journal-title":"CNS Spectr"},{"issue":"Suppl 16","key":"1103_CR2","first-page":"14","volume":"64","author":"NR Schooler","year":"2003","unstructured":"Schooler NR: Relapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry. 2003, 64 (Suppl 16): 14-17.","journal-title":"J Clin Psychiatry"},{"key":"1103_CR3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.4088\/JCP.v69n1004","volume":"69","author":"MX Patel","year":"2008","unstructured":"Patel MX, de Zoysa N, Bernadt M, David AS: A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral. J Clin Psychiatry. 2008, 69: 1548-1556.","journal-title":"J Clin Psychiatry"},{"key":"1103_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.psychres.2008.09.004","volume":"170","author":"IA Lipkovich","year":"2009","unstructured":"Lipkovich IA, Deberdt W, Csernansky JG, Buckley P, Peuskens J, Kollack-Walker S, Rotelli M, Houston JP: Defining \"good\" and \"poor\" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approach. Psychiatry Res. 2009, 170: 161-167.","journal-title":"Psychiatry Res"},{"key":"1103_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR: Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005, 162: 441-449.","journal-title":"Am J Psychiatry"},{"key":"1103_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1176\/appi.ajp.2009.07081221","volume":"167","author":"JM Kane","year":"2010","unstructured":"Kane JM, Detke HC, Naber D, Sethuraman G, Lin DY, Bergstrom RF, McDonnell D: Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. Am J Psychiatry. 2010, 167: 181-189.","journal-title":"Am J Psychiatry"},{"key":"1103_CR7","doi-asserted-by":"publisher","first-page":"S464","DOI":"10.1016\/S0924-977X(10)70681-7","volume":"20","author":"HC Detke","year":"2010","unstructured":"Detke HC, Weiden PJ, Lambert T, Llorca PM, Choukour M, Watson SB, Brunner E, Ascher-Svanum H: Olanzapine long-acting injection vs. oral olanzapine in schizophrenia outpatients: A 2-year, randomized, open-label study. Eur Neuropsychopharmacol. 2010, 20: S464-","journal-title":"Eur Neuropsychopharmacol"},{"key":"1103_CR8","volume-title":"Long-term open-label safety of olanzapine long-acting injection: 190 week interim results","author":"DP McDonnell","year":"2009","unstructured":"McDonnell DP, Detke HC, Zhao F, Watson SB: Long-term open-label safety of olanzapine long-acting injection: 190 week interim results. 2009, San Francisco, CA, USA: Poster presented at the 162nd Annual Meeting of the American Psychiatric Association"},{"key":"1103_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF01064966","volume":"61","author":"SR Kay","year":"1990","unstructured":"Kay SR: Positive\u2013negative symptom assessment in schizophrenia: psychometric issues and scale comparison. Psychiatr Q. 1990, 61: 163-178.","journal-title":"Psychiatr Q"},{"key":"1103_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4088\/JCP.v58n1205","volume":"58","author":"SR Marder","year":"1997","unstructured":"Marder SR, Davis JM, Chouinard G: The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry. 1997, 58: 538-546.","journal-title":"J Clin Psychiatry"},{"key":"1103_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","volume":"10","author":"DW Heinrichs","year":"1984","unstructured":"Heinrichs DW, Hanlon TE, Carpenter WT: The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984, 10: 388-398.","journal-title":"Schizophr Bull"},{"key":"1103_CR12","volume-title":"Classification and regression trees","author":"L Breiman","year":"1983","unstructured":"Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and regression trees. 1983, Belmont, CA, USA: Wadsworth"},{"key":"1103_CR13","first-page":"218","volume-title":"Clinical Global Impressions: In ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W: Clinical Global Impressions: In ECDEU Assessment Manual for Psychopharmacology. 1976, Rockville, MD: National Institute for Mental Health, 218-222. Revised DHEW Pub. (ADM)"},{"key":"1103_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.4088\/JCP.v67n0804","volume":"67","author":"GM Simpson","year":"2006","unstructured":"Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM: A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2006, 67: 1194-1203.","journal-title":"J Clin Psychiatry"},{"key":"1103_CR15","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4088\/JCP.v64n1017","volume":"64","author":"WW Fleischhacker","year":"2003","unstructured":"Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, Martin S, Gefvert O: Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic. J Clin Psychiatry. 2003, 64: 1250-1257.","journal-title":"J Clin Psychiatry"},{"key":"1103_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1185\/03007990903488670","volume":"26","author":"J Peuskens","year":"2010","unstructured":"Peuskens J, Olivares JM, Pecenak J, Tuma I, Bij de Weg H, Eriksson L, Resseler S, Akhras K, Jacobs A: Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries. Curr Med Res Opin. 2010, 26: 501-509.","journal-title":"Curr Med Res Opin"},{"key":"1103_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00406-010-0117-y","volume":"260","author":"HJ M\u00f6ller","year":"2010","unstructured":"M\u00f6ller HJ, J\u00e4ger M, Riedel M, Obermeier M, Strauss A, Bottlender R: The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci. 2010, 260: 367-384.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1103_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.eurpsy.2009.09.001","volume":"25","author":"M Lambert","year":"2010","unstructured":"Lambert M, De Marinis T, Pfeil J, Naber D, Schreiner A: Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment. Eur Psychiatry. 2010, 25: 220-229.","journal-title":"Eur Psychiatry"},{"key":"1103_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/YCO.0b013e3282f33f76","volume":"21","author":"R Emsley","year":"2008","unstructured":"Emsley R, Chiliza B, Schoeman R: Predictors of long-term outcome in schizophrenia. Curr Opin Psychiatry. 2008, 21: 173-137.","journal-title":"Curr Opin Psychiatry"},{"key":"1103_CR20","first-page":"114","volume":"24","author":"R Emsley","year":"2011","unstructured":"Emsley R, Chiliza B, Asmal l, Lehloenya K: The concepts of remission and recovery in schizophrenia. Curr Opin Psychiatry. 2011, 24: 114-121.","journal-title":"Curr Opin Psychiatry"},{"key":"1103_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1176\/ajp.2006.163.4.611","volume":"163","author":"TS Stroup","year":"2006","unstructured":"Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK, CATIE Investigators: Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry. 2006, 163: 611-622.","journal-title":"Am J Psychiatry"},{"key":"1103_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.jcp.0000246215.49271.b8","volume":"26","author":"JM Haro","year":"2006","unstructured":"Haro JM, Novick D, Suarez D, Alonso J, L\u00e9pine JP, Ratcliffe M, SOHO Study Group: Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study. J Clin Psychopharmacol. 2006, 26: 571-578.","journal-title":"J Clin Psychopharmacol"},{"key":"1103_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1192\/bjp.177.5.421","volume":"177","author":"M Harrow","year":"2000","unstructured":"Harrow M, Grossman LS, Herbener ES, Davies EW: Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry. 2000, 177: 421-426.","journal-title":"Br J Psychiatry"},{"key":"1103_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","volume":"161","author":"DG Robinson","year":"2004","unstructured":"Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM: Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004, 161: 473-479.","journal-title":"Am J Psychiatry"},{"key":"1103_CR25","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.4088\/JCP.v67n1104","volume":"67","author":"M Lambert","year":"2006","unstructured":"Lambert M, Schimmelmann BG, Naber D, Schacht A, Karow A, Wagner T, Czekalla J: Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry. 2006, 67: 1690-1697.","journal-title":"J Clin Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T21:13:51Z","timestamp":1468358031000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,31]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-130","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,31]]},"article-number":"130"}}